The GPHN Knockout A-549 Polyclonal Cells product provides a heterogeneous pool of A-549 human lung adenocarcinoma epithelial cells that have been subjected to CRISPR/Cas9-mediated disruption of the GPHN locus. This polyclonal knockout population is generated without single-cell cloning, yielding a mixture of loss-of-function alleles that collectively ablate gephyrin protein expression. The cells serve as a versatile loss-of-function model for dissecting gephyrin-dependent molecular mechanisms in a well-characterized cancer cell background.
The parental A-549 cell line, originally derived from a 58-year-old male patient with lung adenocarcinoma, exhibits an adherent epithelial morphology and is widely employed as a model for non-small-cell lung cancer. These cells are routinely utilized in cancer biology research, including drug screening, signal transduction studies, and migration assays, making them an appropriate host for interrogating the tumorigenic roles of genes such as GPHN.
Gephyrin is best known as a postsynaptic scaffolding protein that clusters glycine and GABA_A receptors at inhibitory synapses through interactions with collybistin, the glycine receptor beta subunit, and GABA_A receptor subunits. Beyond its neuronal function, gephyrin participates in molybdenum cofactor biosynthesis and has been implicated in mTOR signaling. In epithelial cells, gephyrin interacts with Rictor and mTOR, components of mTORC2, and mediates phosphorylation of Akt at Ser473 in response to upstream cues such as EGF, IGF-1, and insulin, thereby linking growth factor signaling to cell survival and cytoskeletal dynamics through downstream targets including Rho GTPases and the actin cytoskeleton.
In the A-549 lung adenocarcinoma context, gephyrin-mediated activation of mTORC2-Akt signaling may drive pro-survival and pro-migratory phenotypes. Disruption of GPHN in these polyclonal cells enables researchers to assess the contribution of gephyrin to PI3K-Akt pathway activity, cancer cell motility, and sensitivity to mTOR inhibitors. This model is particularly relevant for studying mechanisms of metastasis and for evaluating therapeutic vulnerabilities in lung adenocarcinoma, a disease frequently associated with aberrant Akt signaling.
Typical experimental applications include Western blotting for Akt Ser473 phosphorylation to monitor mTORC2 output, wound healing and Transwell assays to quantify cell migration and invasion, co-immunoprecipitation of Rictor or mTOR to probe complex integrity, and immunofluorescence to examine gephyrin localization. Transcriptomic analysis via RNA-seq can reveal global changes upon knockout, and neuronal co-culture models enable studies of synapse formation. For additional information, please contact Ascent Research.
